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Objectives: The aim of the present study was to evaluate our technique of thyroid ﬁne-needle
aspiration cytology (FNAC), its limitations and means of improvement by comparing our results
with those of literature.
Material and methods: Thyroid FNAC results from 117 consecutive patients (May 2006 to July
2007) were categorized into four groups: benign, with suspected malignancy, malignant and
unrepresentative. The FNAC results were compared with histopathologic analysis after thy-
roidectomy.
Results: All ‘‘benign’’ and ‘‘malignant’’ FNAC ﬁndings were conﬁrmed on ﬁnal histology. All
‘‘suspect’’ FNAC ﬁndings were benign on histology. Cytological diagnosis of malignancy was
consistent with histological examination in all cases. Sensitivity was 100% (no false negatives),
speciﬁcity 67% (28% false positives), positive predictive value 72% and negative predictive
value 100%. There was a signiﬁcant difference in the proportion of ‘‘unrepresentative’’ results
between two of the operators performing aspiration (51% versus 29.2%).
Conclusions: The main pitfall of FNAC in thyroid pathology is the ‘‘suspect’’ category, for which
positive diagnosis is founded on histological criteria alone. The second limitation identiﬁed
in this study was the high number of ‘‘unrepresentative’’ aspirates. However, the technique
remains useful.
© 2011 Published by Elsevier Masson SAS.
mIntroductionPalpable thyroid nodules are found in 4 to 7% of the adult
population; less than 5% of thyroid nodules, however, are
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doi:10.1016/j.anorl.2011.01.003alignant [1]. Given this prevalence and malignancy risk,
eliable and precise examination is needed.
Fine-needle aspiration cytology (FNAC) is increasingly
sed: it is a quick, noninvasive and reliable means of
etecting cancerous thyroid nodules and, in many cases,
f avoiding systematic resort to surgery [2]. Since FNAC
as developed, the rate of thyroid surgery has decreased
emarkably [1]. Despite its recognized interest, however, it
.

















































Figure 1 Microscopic view of thyroiditis: cluster of follicular









as various drawbacks, such as a high rate of incomplete
spiration, an inability to distinguish follicular adenoma
rom follicular carcinoma, and a risk of false negatives and
alse positives [3,4].
The present study assessed our own technique, its limits
nd the means to improve it, by comparing our results with
hose of the literature.
aterial and methods
prospective study included 101 patients and 117 thyroid
odules, receiving a single FNAC, over a 14-month period
rom May 2006 to July 2007. Ultrasound-guided FNAC was
erformed by four different operators (O1, O2, O3 and
4).
Aspirates were sent to the Anatomy and Pathologic
ytology Department of our institution. They concerned
ne, two or three nodules, detected on ultrasound. The
umber of smears per nodule ranged from six to 30
lides; each nodule was studied separately. Sixty-four of
he 117 nodules were checked in surgery, without prior
election. After study, samples were classiﬁed according
o cytological aspect into four groups, following current
uidelines [1]: unrepresentative, benign, suspect or malig-
ant.
The surgical specimens came either from total thyroidec-
omy or from lobectomy or lobo-isthmectomy. They were
ent to the Pathologic Anatomy Department, with a form
etailing the clinical data or the patient’s ﬁle in case of
xtemporaneous examination. They were then examined,
ampled, prepared and interpreted.
Statistical analysis focused on performance indica-
ors assessing FNAC in terms of screening efﬁcacy and
f operator performance. The performance indicators
or screening efﬁcacy were: sensitivity (Ss), speciﬁcity
Sp), positive predictive value (PPV) and negative pre-
ictive value (NPV). Operator performance was assessed
n Pearson’s Chi2, comparing percentage unrepresen-
ative samples. The signiﬁcance threshold was set at
< 0.05.
esults
orty-four of the 117 sampled nodules were classiﬁed as
nrepresentative (37.6%), 36 benign (30.8%), 30 suspect
25.6%) and seven malignant (6%).
The 36 benign aspirates comprised one thyroiditis
Fig. 1), two cysts and 33 adenomas (six mixed (macro- and
icrovesicular) and 27 macrovesicular (Fig. 2).
The seven malignant aspirates showed an aspect of
apillary carcinoma in four cases (Fig. 3), anaplastic car-
inoma in one (Fig. 4), mixed (vesicular and medullary)
arcinoma in one, and medullary carcinoma in one.
Only 64 of the 117 sampled nodules were operated on
54.7%). Histological examination of serial cross-sections of
he 64 nodules determined tumor type on the histological
lassiﬁcation of thyroid tumors (WHO 2003) [23], based on
orphologic data and architectural type: 14 benign, 19 sus-




cigure 2 Microscopic view of macrovesicular adenoma: fol-
icular cells with macrovesicular arrangement (MGG× 20).
enign aspirates
ll aspirates considered benign on cytology (14 nodules)
roved benign on histology; these were all macrovesicular
denomas.
alignant aspirates
ll aspirates considered malignant on cytology (6 nodules)
roved malignant on histology: three papillary carcinomas,
ne vesicular-type papillary carcinoma, one mixed vesicu-
ar/medullary carcinoma, and one esophageal epidermoid
arcinoma inﬁltrating the thyroid.
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Table 1 Distribution of the cytology results according to deﬁnitive histologic examination.
Cytology Benign Malignant Suspect Unrep. Total
Histology
Benign 14 (100%) 0 19 (100%) 21 (84%) 54
Malignant 0 6 (100%) 0 4 (16%) 10
Papillary carcinoma 0 3 0 3 6
Vesic. papillary carcinoma 0 1 0 0 1
Papillary Microc 0 0 0 1 1
Mixed carcinoma 0 1 0 0 1
Epid. carcinoma 0 1 0 0 1
















nFigure 3 Microscopic view of papillary carcinoma: numerous
papillae with thin conjunctive axis (MGG× 10).
Suspect aspirates
All aspirates considered suspect on cytology (19 nodules)
proved benign on histology: 10 microvesicular adenomas
(eight within goiter, two isolated), three macrovesicular
adenomas, two oncocytic adenomas, one papillary adenoma
and three thyroidites.
Unrepresentative aspirates
Four of the 25 aspirates considered unrepresentative on
cytology proved malignant (16%), and 21 benign (84%).
The four malignant nodules considered unrepresentative on
cytology proved to be papillary carcinomas.
Statistical analysis discounted aspirates considered
unrepresentative on cytology. Results were assessed ﬁrst
overall and then according to histologic type, grouping
cytologically suspect and malignant aspirates together, and
considering suspect aspirates involving isolated or goiter-
related microvesicular and oncocytic adenomas as true
positives.
There were thus 18 (46%) positive aspirates with malig-
nant tumor or oncocytic/microvesicular tumor on histology
(true positive (TP)): three classic papillary carcinomas, one
mixed carcinoma, one vesicular papillary carcinoma, one
epidermoid carcinoma, two oncocytic adenomas and 10
h
a
ﬁigure 4 Microscopic view of anaplastic carcinoma: numerous
arge cells with monstrous mitotic nucleus (MGG× 10).
icrovesicular adenomas (eight within goiter, two isolated);
o negative aspirates proved malignant on histology (false
egative (FN)); seven positive aspirates (18%) proved benign
n histology (false positive (FP)): three thyroidites, one
apillary adenoma and three macrovesicular adenomas; and
4 negative aspirates (36%) also proved benign on histology
true negative (TN)): all macrovesicular adenomas, either
solated or within goiter.
From these results, the following parameters were cal-
ulated:
sensitivity (TP/TP + FN): Ss = 18/18 + 0 = 100%, with 95%
conﬁdence interval (95% CI): 78—100;
speciﬁcity (TN/TN+ FP): Sp = 14/14 + 7 = 67%; 95% CI,
43—85;
positive predictive value (TP/TP + FP):
PPV = 18/18 + 7 = 72%; 95% CI, 50—87;
and negative predictive value (TN/TN+ FN):
NPV = 14/14 + 0 = 100%; 95% CI, 73 — 100.
The Chi2 test showed cytology to have signiﬁcant diag-
ostic value in predicting malignant or benign status on
istology: P = 2× 10−5, a satisfactory value for sensitivity
nd negative predictive value.
Operator O1 performed 49 FNACs: 25 (51%) were classi-
ed as unrepresentative, 11 (22.4%) as benign, 12 (24.5%) as
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Table 2 Sensitivity and speciﬁcity of ﬁne needle aspiration cytology according to series.
Series Number of FNACs Se (%) Sp (%) PPV (%) NPV (%)
Cheung et al. [10] 179 54 100 100 75
Amrikachi al. [14] 354 93 96 —
Słowin´ska-Klencka et al. [15] 3782 69 86 24 98
Leenhardt et al. [16] 450 94 63 40 98
El Hag et al. [26] 67 85.7 97.6 —
Leonard et al. [27] 184 88 78 46 97
Cãp et al. [28] 536 86 74 34 97
Morgan et al. [29] 253 55 73.7 —
Screaton et al. [30] 199 61 100 —







































































Se: sensitivity; Sp: speciﬁcity; PPV: positive predictive value; NPV
uspect, and one (2%) as malignant. During the last 6months,
1 performed 18 (49%) unrepresentative FNACs.
Operator O2 performed 65 FNACs: 19 (29.2%) were clas-
iﬁed as unrepresentative, 24 (36.9%) as benign, 18 (27.7%)
s suspect, and four (6.2%) as malignant. During the last
months, O2 performed six (18.5%) unrepresentative FNACs.
Operator O3 performed only one FNAC, classiﬁed as
enign, and conﬁrmed on histology; operator O4 performed
nly two FNACs, classiﬁed as malignant, and conﬁrmed on
istology.
The difference in the rates of cytologically unrepresen-
ative aspirates between operators O1 and O2 (51% versus
9.2%) was signiﬁcant (P = 0.02). Operators O3 and O4 were
xcluded from this analysis, as the number of FNACs involved
as too small for interpretation.
iscussion
hyroid cytology was recognized as the principal means of
xploring thyroid nodules by the French national agency
or development and medical evaluation (Agence nationale
our le développement et l’évaluation médicale [ANDEM])
n 1997 [5,6]. It is a reliable, simple and inexpensive means
f distinguishing between the more frequent benign colloid
esions and the much rarer microvesicular or clearly malig-
ant lesions.
Fine-needle aspiration is the procedure of choice for thy-
oid nodule assessment; ultrasound control is recommended
or nonpalpable nodules, which are mainly cystic or with
osterior location [7]. Ultrasound-guided FNAC is currently
he method of choice, providing precious information on
ocation, size and structure (solid or cystic) and reliable
spirates [8].
Several (2 to 6) aspirates are required per nodule for good
epresentation of the lesion. Slide smears are performed as
n other cytological sampling procedures.
Cytologic diagnosis is founded on a range of parameters,
nalyzing background and cellular elements [1].
The current consensus distinguishes four categories of
NAC aspirate: unrepresentative, benign, suspect or malig-
ant [1]. ‘‘Unrepresentative’’ applies when the smear
s noninterpretable due to lack of material (less than
to 12 clusters), defective technique or colloid, hemal
a
p
l100 67 72 100
ative predictive value.
r necrotic material overwhelming the follicular cells.
‘Benign’’ applies to a cytologic aspect of benignity, and is
uggestive of macrovesicular adenoma, cyst or thyroiditis.
‘Suspect’’ applies to a cytologic aspect that is ambiva-
ent between benignity and malignancy, and corresponds to
icrovesicular or oncocytic tumor. ‘‘Malignant’’ applies to
cytologic aspect of malignancy, and is suggestive of papil-
ary, medullary or anaplastic carcinoma.
The present results agree with those of the literature.
ll aspirates considered benign on cytology were con-
rmed as such on histology; these were the true negatives,
hich in the literature range from 74 to 97%, compared to
alse-negative rates of 3 to 26%. All aspirates considered
alignant on cytology were conﬁrmed as such on histology;
ates in the literature range from 94 to 100% [9,10]. No aspi-
ates considered suspect on cytology proved malignant on
istology; in the literature, these rates vary from 23 to 46%
9,10].
This high rate of suspect aspirates proving benign on his-
ology was probably due to sampling microvesicular nodules
n areas of goiter. Suspect aspirates found to concern thy-
oiditis on histology were classiﬁed as such by the cytologist
ue to the poorly cellular nature of the smear, the rarity of
ymphocytes and the abundance of oncocytes.
In calculating true and false positive rates, literature
eports combine suspect and malignant cytology ﬁndings.
n the present study, we did likewise, while considering sus-
ect aspirates that proved to be microvesicular or oncocytic
denomas as true positive. This gave a true-positive rate of
2% and a false-positive rate of 28%, in agreement with the
iterature (38—72% and 28—62%, respectively [9—13]).
In the present series, sensitivity was 100%, speciﬁcity
7%, positive predictive value 72% and negative predictive
alue 100%, with P = 2× 10−5.
Conversely, in the largest published series, including
ore than 200 nodules, most authors treated microvesicular
nd oncocytic adenoma as false positive [12,14—16]. Sensi-
ivity ranged from 54 to 94%, speciﬁcity from 63 to100%,
ositive predictive value from 24 to 100% and negative pre-
ictive value from 75 to 98%. This method could not be
pplied in small series such as the present, due to lack of
ower (Table 2).
In all, the present technique, in agreement with the
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was, however, less effective, indeed unsatisfactory, for
microvesicular and oncocytic tumors, where only histology
determined malignancy or benignity.
In case of unrepresentative aspirate, repeat aspiration
under ultrasound guidance enables cytologic diagnosis in 75%
of solid and 50% of cystic nodules [7], whence the interest
of repeat examination.
Several studies have highlighted the limits of FNAC in thy-
roid nodule diagnosis: these consist mainly in the ‘‘suspect’’
category of microvesicular and oncocytic tumor, the FNAC
technique, and operator and cytologist experience [17—19].
The ‘‘suspect’’ category
Microvesicular tumor
In microvesicular tumor, malignancy is diagnosed from
capsule rupture and vascular invasion detected only on his-
tology. Cytologic diagnosis of vesicular carcinoma is thus
difﬁcult or impossible. Rich cellularity, microvesicular archi-
tecture and nuclear alteration found on cytology, however,
indicate suspicion of vesicular carcinoma [20].
Oncocytic tumor
The cells constituting oncocytic tumors are particular in
terms of morphology, ubiquity and unknown origin. In the
thyroid gland, they may be malignant or benign. They are
easy to detect on cytology; but, as with microvesicular
tumors, there are no reliable cytological criteria of malig-
nancy/benignity [21].
They are also encountered in lymphocytic thyroiditis
when the lymphoid contingent is small. Histological veriﬁ-
cation is mandatory [20].
FNAC technique
All aspirations were performed under ultrasound guidance,
but by 4 different operators. There was a signiﬁcant dif-
ference in ‘‘unrepresentative’’ aspirate rates between two
of them (P = 0.02), with distinct improvement over the last
6months for one but not for the other.
There have been many reports of cost-effectiveness of
FNAC with and without ultrasound guidance, but none focus-
ing on interoperator variability. All agreed that ultrasound
guidance is an important factor, reducing the rate of unrep-
resentative sampling [13,17—19].
Cytologist experience
Cytologist inexperience was often reported as a limitation
in thyroid FNAC, due to the ‘‘suspect’’ category includ-
ing microvesicular and oncocytic tumors. Variable cytologist
response has been demonstrated for this category, even for
a single given lesion [22].
The present study used the simple histological clas-
siﬁcation of thyroid tumors (WHO 2003) [23], based on
morphological data and architectural type.In October 2007, a meeting about ﬁne-needle aspiration
cytology in thyroid nodules was held in Bethesda, DC, with a
large panel of pathologists, endocrinologists and surgeons.
The terminology recommended had a double advantage:
[163
t was based on precise cytological criteria, described in
cytology atlas published in October 2009 (The Bethesda
ystem for Reporting Thyroid Cytopathology) [24], and was
orrelated to cancer risk [25].
onclusion
hyroid nodule is very frequent, and raises issues of man-
gement. The incidence of palpable nodules in adults is
stimated at 4—7%, but is in fact higher, as 30% of asymp-
omatic subjects are carriers of thyroid nodules, less than
% of which are cancerous. The interest of thyroid ﬁne-
eedle aspiration cytology is now fully established. It is a
uick, noninvasive and inexpensive screening examination,
etecting those few of a large number of nodules that show
alignancy.
The pitfalls of cytology in thyroid pathology largely lie
n the ‘‘suspect’’ category, dominated by microvesicular
nd oncocytic thyroid lesions in which positive diagno-
is depends on purely histological criteria. The second
imitation found in the present study was the high rate of
‘unrepresentative’’ aspirates. The technique nevertheless
emains useful.
onﬂict of interest statement
one.
eferences
[1] Gharib H, Goellner JR. Fine-needle aspiration biopsy of the
thyroid: an appraisal. Ann Intern Med 1993;118:282—9.
[2] Ashcraft MW, Van Herle AJ. Management of thyroid nodules:
scanning techniques, thyroid suppressive therapy, and ﬁne nee-
dle aspiration. Head Neck Surg 1981;3:297—322.
[3] Bajaj Y, De M, Thompson A. Fine needle aspiration cytology in
diagnosis and management of thyroid disease. J Laryngol Otol
2006;120:467—9.
[4] Ko HM, Jhu IK, Yang SH, et al. Clinicopathologic analysis of
ﬁne needle aspiration cytology of the thyroid. A review of
1,613 cases and correlation with histopathologic diagnoses.
Acta Cytol 2003;47:727—32.
[5] Agence Nationale pour le développement et l’Evaluation Médi-
cale (ANDEM): la prise en charge diagnostique du nodule
thyroïdien. Recommandations pour la pratique clinique. Nor-
bert Attali Ed. 1997;121—40.
[6] Bennedbaek FN, Hegedüs L. Management of the solitary thyroid
nodule: results of the North American survey. J Clin Endocrinol
Metab 2000;85:2493—8.
[7] Cooper DS, Doherty GM, et al. Revised American Thyroid
Association management guidelines for patients with thyroid
nodules and differentiated thyroid cancer. Thyroid 2009;19:
1167—214.
[8] Baskin HJ, Duick DS. The endocrinologists’ view of ultra-
sound guidelines for ﬁne needle aspiration. Thyroid 2006;16:
207—8.
[9] Sclabas GM, Staerkel GA, Shapiro SE, et al. Fine needle
aspiration of the thyroid and correlation with histopathol-
ogy in contemporary series of 240 patients. Am J Surg
2003;186:702—10.
10] Cheung YS, Poon CM, Mak SM, et al. Fine needle aspiration





















11] Mahar SA, Husain A, Islam N. Fine needle aspiration cytology
of thyroid nodule: diagnostic accuracy and pitfalls. J Ayub Med
Coll Abbottabad 2006;18:26—9.
12] Brooks AD, Shaha AR, DuMornay W, et al. Role of ﬁne-
needle aspiration biopsy and frozen section. Analysis in the
surgical management of thyroid tumors. Ann Surg Oncol
2001;8:92—100.
13] Martínek A, Dvorácková J, Honka M, et al. Importance of
guided ﬁne needle aspiration cytology (FNAC) for the diag-
nostics of thyroid nodules — own experience. Biomed Papers
2004;148:45—50.
14] Amrikachi M, Ramzy I, Rubenfeld S, et al. Accuracy of
ﬁne-needle aspiration of thyroid. Arch Pathol Lab Med
2001;125:484—8.
15] Słowin´ska-Klencka D, Klencki M, Sporny S, et al. Fine-needle
aspiration biopsy of the thyroid in an area of endemic goitre:
inﬂuence of restored sufﬁcient iodine supplementation on the
clinical signiﬁcance of cytological results. Eur J Endocrinol
2002;146:19—26.
16] Leenhardt L, Hejblum G, Franc B, et al. Indications and limits of
ultrasound-guided cytology in the management of nonpalpable
thyroid nodules. J Clin Endocrinol Metab 1999;84:24—8.
17] Mittendorf EA, Tamarkin SW, McHenry CR. The results of
ultrasound-guided ﬁne-needle aspiration biopsy for evaluation
of nodular thyroid disease. Surgery 2002;132:648—54.
18] Cai XJ, Valiyaparambath N, Nixon P, et al. Ultrasound-guided
ﬁne needle aspiration cytology in the diagnosis and manage-
ment of thyroid nodules. Cytopathology 2006;17:251—6.
19] Mehrotra P, Viswanathan H, Johnson SJ, et al. Ultrasound
guidance improves the adequacy of our preoperative thyroid
cytology but not its accuracy. Cytopathology 2006;17:137—44.
20] Ravetto C, Colombo L, Dottorini ME. Usefulness of ﬁne-
needle aspiration in the diagnosis oh thyroid carcinoma:
[
[M. Sellami et al.
a retrospective study in 37.875 patients. Cancer 2000;90:
357—63.
21] Guyetant S, Michalak S, Valo I, et al. Diagnosis of the follicular
variant of papillary thyroid carcinoma. Signiﬁcance of immuno-
histochemestry. Ann Pathol 2003;23:11—20.
22] Renshaw AA, Wang E, Wilbur D, et al. Interobserver Agreement
on microfollicles in thyroid ﬁne-needle aspirates. Arch Pathol
Lab Med 2006;130:148—52.
23] Cibas ES, Ali SZ. The bethesda system for reporting thyroid
cytopathology. Thyroid 2009;19:1159—65.
24] DeLellis RA, Lloyd RV, Heitz PU, et al, eds. Pathology and Genet-
ics of Tumours of Endocrine Organs. Lyon, France: IARC Press;
2004. World Health Organization Classiﬁcation of Tumours.
25] Cibas ES, Alexander EK, Benson CB, et al. Indications for thy-
roid FNA and pre-FNA requirements: a synopsis of the National
Cancer Institute Thyroid Fine-Needle Aspiration State of the
Science Conference. Diagn Cytopathol 2008;36:390—9.
26] El Hag IA, Kollur SM, Chiedozi LC. The role of FNA in the initial
management of thyroid lesions: 7-year experience in a district
general hospital. Cytopathology 2003;14:126—30.
27] Leonard N, Melcher DH. To operate or not to operate? The value
of ﬁne needle aspiration cytology in the assessment of thyroid
swellings. J Clin Pathol 1997;50:941—3.
28] Cãp J, Ryska A, Rehorkova P, et al. Sensitivity and speciﬁcity of
the ﬁne needle aspiration biopsy of the thyroid: clinical point
of view. Clin Endocrinol 1999;51:509—15.
29] Morgan JL, Serpell JW, Cheng MS. Fine-needleaspiration
cytology of thyroid nodules: how useful is it? ANZ J Surg
2003;73:480—3.30] Screaton NJ, Berman LH, Grant JW. US-guided core-needle
biopsy of the thyroid gland. Radiology 2003;226:827—32.
31] Lioe TF, Elliott H, Allen DC, et al. A 3-year audit of thyroid ﬁne
needle aspirates. Cytopathology 1998;9:188—92.
